Can Wegovy (Semaglutide) Cause Anxiety?

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 20th, 2026.

Published on July 17th, 2026. Updated on July 20th, 2026.

Key takeaways

  • Anxiety is not a confirmed common side effect of semaglutide, but real-world reports and GLP-1 receptor activity in the brain mean the possible connection should not be dismissed.

  • Physical side effects like nausea, rapid heart rate, and blood sugar dips can directly produce or worsen anxiety-like sensations, making it hard to tell the cause apart.

  • Tracking anxiety symptoms relative to your injection day is a practical first step to spotting a possible drug-related pattern.

  • People with a personal or family history of anxiety disorders should discuss this risk explicitly with their prescriber before starting or escalating semaglutide.

  • Suicidal ideation or severe psychiatric symptoms after starting semaglutide require immediate contact with a clinician, not a wait-and-see approach.

What the Clinical Data Actually Says About Semaglutide and Anxiety

If you have started Wegovy or Ozempic and noticed a shift in your mood or an uptick in worry, you are not imagining things. At the same time, anxiety does not appear as a commonly listed side effect in the official prescribing information for either medication. So where does that leave you?

The reality is more nuanced. The FDA Adverse Event Reporting System (FAERS) includes entries for anxiety and panic attacks linked to semaglutide use submitted by real patients and clinicians. These are post-marketing reports, meaning they emerged after the drug reached widespread use, not from the controlled clinical trials that initially approved the medication.

Those trials were designed primarily to measure GI tolerability and cardiovascular outcomes. Mental health effects were not systematically tracked, leaving a meaningful gap in the evidence. The FDA has also flagged GLP-1 receptor agonists as a class for ongoing monitoring regarding psychiatric signals, including suicidal ideation. That monitoring does not confirm a causal link, but it does signal that regulators take the question seriously.

How the Brain May Be Involved

Semaglutide works by mimicking a naturally occurring hormone called GLP-1 (glucagon-like peptide-1). GLP-1 receptors are not limited to the gut and pancreas. They are also expressed in brain regions directly involved in emotion regulation, including the amygdala and hypothalamus.

Animal studies suggest that GLP-1 agonists can influence stress responses and fear-related circuits in the brain, though results vary depending on dose and duration of exposure. This biological plausibility means that a mood or anxiety effect is not far-fetched, even if it has not been pinned down precisely in human trials.

There is also the gut-brain axis to consider. When semaglutide causes nausea, bloating, or GI discomfort, those physical signals travel back to the brain through well-established nerve pathways. Chronic GI distress has long been associated with mood changes and heightened anxiety in people without any medication involved, so it is reasonable to expect a similar dynamic here.

Physical Side Effects That Look and Feel Like Anxiety

One of the most important things to understand is that several common semaglutide side effects can feel almost identical to anxiety or a panic attack. Distinguishing between the two requires paying close attention to timing and context.

Symptom

True Anxiety Indicator

Semaglutide Physical Effect That Looks Similar

Racing heart

Triggered by worry, stress, or fearful thoughts

May follow injection due to autonomic nervous system changes

Shakiness or trembling

Linked to nervous anticipation or panic

Can indicate hypoglycemia, especially when combined with other diabetes medications

Nausea or stomach upset

Tied to dread or chronic stress

Very common GI side effect, especially during dose escalation

Dizziness or lightheadedness

Associated with hyperventilation during panic

Can result from low blood sugar or dehydration on semaglutide

Sleep disruption

Rumination, worry at night

GI discomfort disrupting sleep, which then worsens baseline anxiety

Hypoglycemia deserves special attention. When semaglutide is used alongside other diabetes medications such as insulin or sulfonylureas, blood sugar can drop low enough to produce shakiness, sweating, and a sense of dread that mirrors a classic anxiety episode.

Who May Be at Higher Risk

Not everyone on semaglutide will notice anxiety-related changes, but certain factors may increase the likelihood.

People with a personal or family history of anxiety disorders or panic attacks may be more sensitive to any medication that influences the nervous system. If anxiety has been part of your history, that context is worth discussing explicitly with your prescriber before starting or moving to higher doses.

Dose escalation is another risk window. Semaglutide is typically started at a low dose and increased gradually over months. Side effects, including those that may feel anxiety-like, tend to be most pronounced during those upward steps rather than at a stable maintenance level.

Lifestyle stress during treatment also matters. Rapid weight loss, while often welcome, can bring its own psychological adjustment challenges. Changes in body image, social dynamics around food, and shifts in daily routine can all contribute to heightened emotional sensitivity during treatment.

What to Do If You Notice Anxiety Symptoms

If you are experiencing anxiety while on semaglutide, a structured approach can help you and your clinician figure out what is actually happening.

Start by tracking symptom timing relative to your injection day. Semaglutide reaches peak levels in the body roughly 24 to 72 hours after injection. If your anxiety tends to spike in that window and then ease off, a drug-level connection becomes more plausible.

Do not stop the medication abruptly without guidance. Discontinuation should be managed with your prescriber to avoid rebound effects and to make sure the decision is based on a full picture of your health. Bring your symptom log to the conversation so the discussion is grounded in specifics.

Report new or worsening anxiety promptly, and act immediately if you notice any thoughts of self-harm or suicide. The FDA has specifically flagged this possibility across GLP-1 medications for ongoing monitoring, and it warrants urgent clinical attention, not a wait for your next scheduled appointment.

Signs that require immediate medical evaluation include severe or sudden-onset panic attacks that interfere with your ability to function, anxiety accompanied by chest pain or signs of thyroid problems such as a lump in the neck or difficulty swallowing, and any psychiatric symptoms that feel markedly out of character for you. These situations call for same-day contact with a clinician rather than watchful waiting at home.

Frequently Asked Questions

Panic attacks are not listed as a common side effect in Wegovy's prescribing information, but they appear in post-marketing reports submitted to the FDA. Physical side effects like a racing heart, dizziness, and nausea can also mimic or trigger panic symptoms, making it difficult to know whether the drug is a direct cause or an indirect contributor.

For some users, anxiety-like symptoms improve as the body adjusts to the medication, particularly after the dose escalation phase. However, if symptoms are persistent, worsening, or interfering with daily life, they should be reported to a clinician. Waiting it out without guidance is not recommended, especially if mental health history is a factor.

You should not stop semaglutide abruptly without consulting your prescriber. Discontinuation needs to be managed carefully to avoid rebound effects. Instead, document your symptoms, note when they occur relative to your injection, and contact your healthcare provider to discuss whether a dose adjustment or further evaluation is appropriate.

Side effects, including those that may contribute to anxiety-like feelings, are often most pronounced during dose escalation rather than at a stable maintenance dose. Higher doses tend to produce more intense GI and cardiovascular side effects, which may worsen anxiety sensations. Individual responses vary, so monitoring symptoms at each dose change is important.

Semaglutide can slow gastric emptying, which may affect how some oral medications are absorbed, including certain SSRIs. No major direct pharmacological interactions with benzodiazepines are currently documented, but combining any medications carries nuance. Always share your full medication list with your prescriber before starting or adjusting semaglutide.

The Bottom Line

The link between semaglutide and anxiety is plausible but not yet fully proven. GLP-1 receptors exist in brain regions tied to mood, physical side effects of the drug can mimic anxiety symptoms, and real-world adverse event reports continue to accumulate. For the millions of people already using Wegovy or Ozempic, understanding this possible connection matters. Doctronic offers free AI consultations and $39 video visits available 24/7, giving you a fast, affordable way to evaluate new symptoms with clinician-level guidance before deciding whether to continue, adjust, or stop treatment. With 99.2% treatment plan alignment with board-certified physicians, you can get informed answers quickly. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get medical advice

Chat Now